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In the vascular system, the NADPH oxidases Nox1, Nox2, Nox4, and Nox5 are expressed. Unlike the case with the other vascular Nox homologues, the activity of Nox4 appears to be predominantly controlled by its expression level, and proinflammatory mediators that induce Nox1 or Nox2 instead appear to suppress Nox4 expression. 3 Nox4 is also the only vascular homolog that directly produces hydrogen peroxide (H 2 O 2 ) and thus is incapable of scavenging nitric oxide (NO) or producing peroxynitrite (ONOO Ϫ ). 4 As a consequence of these unique properties, so far little consensus regarding the physiological function of Nox4 has been reached. 3 In this issue of Arteriosclerosis, Thrombosis, and Vascular Biology, Ray et al report the generation and characterization of a transgenic mouse with endothelial-specific Nox4 overexpression. 5 Vascular segments and endothelial cells of these animals had a significant increase in H 2 O 2 generation that was sufficient to result in a substantial increase in the oxidation of peroxiredoxin 1. Despite these signs of increased protein oxidation, the blood pressure of the animals was lower under basal conditions and after angiotensin II treatment. Furthermore, endothelium-dependent relaxation was enhanced compared with wild-type animals. The latter effects were sensitive to catalase ex vivo and N-acetylcysteine in vivo, suggesting that they were mediated by H 2 O 2 . A further characterization of the nature of the H 2 O 2 -induced vasodilatation indicated that this was mediated by potassium channels and thus was of an endothelium-derived hyperpolarizing factor (EDHF) type.
These observations are most remarkable as they illustrate that the type of ROS released in the vascular system determines whether Nox-dependent redox signaling is beneficial or detrimental. Endothelial-specific overexpression of Nox2, a Nox homologue that generates superoxide anions (O 2 Ϫ· ), promotes vascular dysfunction and oxidative stress. 6 Similar effects were observed with the smooth muscle-specific overexpression of the O 2 Ϫ· -generating Nox1. 7 The general interpretation of these studies is that Nox-derived O 2 Ϫ· reacts with endothelium-derived NO, which lowers the availability of NO and results in the generation of ONOO Ϫ . ONOO Ϫ is highly reactive and oxidizes cysteines and tetrahydrobiopterin, an essential cofactor of the NO synthase. Lack of tetrahydrobiopterin uncouples the enzyme, which further promotes O 2 Ϫ· generation and leads to the establishment of a vicious cycle. 8 Unlike O 2 Ϫ· , H 2 O 2 is incapable of reacting with NO but may even induce and activate the NO synthase. 9 H 2 O 2 has also been shown to act as an endothelium-derived vasodilator in many vascular beds, with a particular strong contribution to the local vasomotion of cerebral vessels.
Not only the type of ROS but also the site of ROS production appears to be of importance. Endothelial-specific overexpression of Nox4, despite a great increase in H 2 O 2 formation, did not result in smooth muscle cell hypertrophy. This observation is remarkable given that hypertrophy is readily achieved by smooth muscle-targeted NADPH oxidase overexpression or direct application of H 2 O 2 . It is possible that the hyperpolarization induced by endotheliumderived H 2 O 2 counteracted hypertrophic signaling in the study by Ray et al. 5 Alternatively, it may illustrate that H 2 O 2 signaling is much more compartmentalized than had long been assumed. Indeed, evidence is accumulating that locally produced H 2 O 2 rapidly reacts with peroxiredoxins, which subsequently mediate signaling by thiol-based redox reactions, 10 although a lot of work still has to be done to establish this pathway as a central intermediator in Nox-derived redox signaling.
Interpretation of the physiological function of Nox4 critically depends on the inability of the enzyme to produce O 2 Ϫ· , and Ray et al 5 support this view, as they found no evidence of increased tyrosine nitration, a footprint marker of ONOO Ϫ and therefore O 2 Ϫ· generation on Nox4 overexpression. In contrast to this, several studies reported O 2 Ϫ· formation by Nox4, but these data were mainly based on microscopy fluorescence measurements with the O 2 Ϫ· -sensitive probe dihydroethidium. In the present work, Ray et al 5 impressively demonstrate that Nox4 increases the fluorescent signal in the dihydroethidium assay but that this is not a consequence of an O 2 Ϫ· -dependent formation of oxyethidium but rather of a H 2 O 2 -mediated direct oxidation of dihydroethidium to ethidium, a reaction that is in fact completely sensitive to catalase. Such caveats for the microscopy evaluation of the dihydroethidium assay have been previously presented by others, too. 11 The conclusion of these observations can only be that fluorescence microscopy should no longer be used to evaluate the dihydroethidium assay and that it should be accepted that Nox4 indeed primarily produces H 2 O 2 .
An important conclusion of the present work by Ray et al 5 could be that Nox4 serves protective functions (Figure) , which is in line with the ability of Nox4 to prevent the transition of cardiac hypertrophy to heart failure by maintaining vascular endothelial growth factor-induced angiogenesis. 12 These findings are contrasted by observations identifying Nox4 as mediator of heart failure after transaortic constriction 13 and of epithelial cell death in the lung. 14 How can these findings be reconciled? Despite the beneficial signaling role of H 2 O 2 in the endothelium, it is still true that excessive concentrations of this oxidant induce inflammation, fibrosis, apoptosis, and even necrosis. Given the rather constitutive activity of Nox4, the regulation of H 2 O 2 formation by the enzyme occurs predominantly on the expression level. Thus, whether Nox4 is harmful or beneficial is primarily a question of dosage. Under certain conditions, such as the release of transforming growth factor-␤1, diabetes, and heart failure, Nox4-dependent H 2 O 2 formation appears to exceed protective levels and even becomes harmful. This is reminiscent of other enzymes involved in redox signaling. Low NO, for example, is beneficial, whereas excessive formation by inducible NO synthase can have harmful effects as well.
One unexpected finding in the present study of Ray et al 5 is that endothelial overexpression of Nox4 improved the stimulated endothelium-dependent relaxation in response to acetylcholine and histamine. This implies that these 2 agonists may enhance Nox4 activity, which is unexpected given the high basal, so-called constitutive activity of the enzyme, which is consistently observed in overexpression systems. In line with the present observations, several reports suggested that despite the high constitutive activity of the enzyme, transforming growth factor-␤1 in particular may acutely further increase Nox4 activity. It is unclear whether this effect involves translocation or phosphorylation of the enzyme, changes in unknown activating factors such as interacting proteins or lipids, or even the availability of the substrate NADPH. 2 In conclusion, with the present work, Ray et al 5 indicate that Nox4 in the endothelium can have beneficial effects by mediating an EDHF-type endothelium-dependent vasodilatation, which is sufficient to systemically lower the blood pressure. This work impressively illustrates that the site and type of ROS generated by Nox proteins are decisive for their function. Future work in Nox4 knockout mice, however, will be required to uncover whether the positive effects elicited by overexpression are also exerted by endogenous Nox4.
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